{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:09:56Z","timestamp":1778821796257,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NCT02103621"],"award-info":[{"award-number":["NCT02103621"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH100444"],"award-info":[{"award-number":["MH100444"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH1000444"],"award-info":[{"award-number":["MH1000444"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cct.2017.12.017","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T13:43:33Z","timestamp":1514987013000},"page":"157-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods"],"prefix":"10.1016","volume":"65","author":[{"given":"Christina L.","family":"Boisseau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2017.12.017_bb0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Suppl","key":"10.1016\/j.cct.2017.12.017_bb0010","first-page":"5","article-title":"The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group","volume":"55","author":"Weissman","year":"1994","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.cct.2017.12.017_bb0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.comppsych.2005.11.006","article-title":"Impact of obsessive-compulsive disorder on quality of life","volume":"47","author":"Eisen","year":"2006","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0020","series-title":"Obs. Disord. Phenomenol. Pathophysiol. Treat","article-title":"Quality of Life and Psychosocial Functioning in OCD","author":"Boisseau","year":"2017"},{"key":"10.1016\/j.cct.2017.12.017_bb0025","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4088\/JCP.v67n0611","article-title":"Treatment of obsessive-compulsive disorder by U.S. psychiatrists","volume":"67","author":"Blanco","year":"2006","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.cct.2017.12.017_bb0030","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.4088\/JCP.v67n1107","article-title":"The brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement","volume":"67","author":"Mancebo","year":"2006","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.cct.2017.12.017_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0b013e3283613e4d","article-title":"Longitudinal course of pharmacotherapy in obsessive\u2013compulsive disorder","volume":"100","author":"Grant","year":"2013","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2017.12.017_bb0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1995.03950160039008","article-title":"Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder","volume":"52","author":"Greist","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archpsyc.1994.03950070051010","article-title":"A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder","volume":"51","author":"Tollefson","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00004714-199708000-00005","article-title":"Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study","volume":"17","author":"Mundo","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2017.12.017_bb0055","doi-asserted-by":"crossref","DOI":"10.3109\/10401230209147454","article-title":"Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, Nefazodone, bupropion, and mirtazapine","volume":"14","author":"Masand","year":"2002","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10401230490281618","article-title":"Tolerability issues during long-term treatment with antidepressants","volume":"16","author":"Cassano","year":"2004","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0065","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881108093582","article-title":"Review: problems associated with long-term treatment with selective serotonin reuptake inhibitors","volume":"23","author":"Moret","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.cct.2017.12.017_bb0070","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4088\/JCP.v65n1011","article-title":"Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors","volume":"65","author":"Maina","year":"2004","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.cct.2017.12.017_bb0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/jcp.0b013e31815152a5","article-title":"Selective serotonin reuptake inhibitor discontinuation","volume":"27","author":"Goethe","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"Suppl. 8","key":"10.1016\/j.cct.2017.12.017_bb0080","first-page":"3","article-title":"Obsessive-compulsive and spectrum disorders: overview and quality of life issues","volume":"57","author":"Hollander","year":"1996","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.cct.2017.12.017_bb0085","first-page":"978","article-title":"Antidepressants in pregnancy: a systematic review","volume":"44","author":"Udechuku","year":"2010","journal-title":"Aust. N. Z. J. Psychiatry."},{"key":"10.1016\/j.cct.2017.12.017_bb0090","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1176\/ajp.145.12.1521","article-title":"Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder","volume":"145","author":"Pato","year":"1988","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0095","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archpsyc.1980.01780240079009","article-title":"Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial","volume":"37","author":"Thor\u00e9n","year":"1980","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0100","first-page":"167","article-title":"Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs)","volume":"32","author":"Ravizza","year":"1996","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.cct.2017.12.017_bb0105","series-title":"Practice guidelines for the Treatment of Patients With Obsessive-compulsive Disorder","author":"American Psychiatric Association","year":"2010"},{"key":"10.1016\/j.cct.2017.12.017_bb0110","series-title":"Unified Protocol for Transdiagnostic Treatment of Emotional Disorders","author":"Barlow","year":"2011"},{"key":"10.1016\/j.cct.2017.12.017_bb0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1037\/0735-7028.33.2.162","article-title":"Cognitive-behavioral therapy with and without medication in the treatment of obsessive-compulsive disorder","volume":"33","author":"Franklin","year":"2002","journal-title":"Prof. Psychol. Res. Pract."},{"key":"10.1016\/j.cct.2017.12.017_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/da.20003","article-title":"Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder","volume":"19","author":"Simpson","year":"2004","journal-title":"Depress. Anxiety."},{"key":"10.1016\/j.cct.2017.12.017_bb0125","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/070674379704201002","article-title":"Behaviour therapy for obsessive\u2014compulsive disorder: a decade of progress","volume":"42","author":"Marks","year":"1997","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.cct.2017.12.017_bb0130","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.brat.2010.04.002","article-title":"Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: further evaluation","volume":"48","author":"Otto","year":"2010","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.cct.2017.12.017_bb0135","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0005-7967(00)00067-X","article-title":"Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series","volume":"39","author":"Whittal","year":"2001","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.cct.2017.12.017_bb0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br. J. Soc. Clin. Psychol."},{"key":"10.1016\/j.cct.2017.12.017_bb0145","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/da.20693","article-title":"Hoarding disorder: a new diagnosis for DSM-V?","volume":"27","author":"Mataix-Cols","year":"2010","journal-title":"Depress. Anxiety."},{"key":"10.1016\/j.cct.2017.12.017_bb0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.15288\/jsas.1994.s12.70","article-title":"Ensuring balanced distribution of prognostic factors in treatment outcome research","volume":"12","author":"Stout","year":"1994","journal-title":"J. Stud. Alcohol Suppl."},{"issue":"11","key":"10.1016\/j.cct.2017.12.017_bb0155","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0160","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.beth.2012.01.001","article-title":"Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial","volume":"43","author":"Farchione","year":"2012","journal-title":"Behav. Ther."},{"key":"10.1016\/j.cct.2017.12.017_bb0165","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/da.20735","article-title":"Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders","volume":"27","author":"Wilamowska","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.cct.2017.12.017_bb0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jamapsychiatry.2017.2164","article-title":"The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders","volume":"74","author":"Barlow","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cbpra.2009.09.003","article-title":"The development of the unified protocol for the transdiagnostic treatment of emotional disorders: a case study","volume":"17","author":"Boisseau","year":"2010","journal-title":"Cogn. Behav. Pract."},{"key":"10.1016\/j.cct.2017.12.017_bb0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/da.20197","article-title":"Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder","volume":"23","author":"Storch","year":"2006","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.cct.2017.12.017_bb0185","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.janxdis.2011.05.007","article-title":"Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: a prospective 1-year follow-up study","volume":"25","author":"Anand","year":"2011","journal-title":"J. Anxiety Disord."},{"issue":"1","key":"10.1016\/j.cct.2017.12.017_bb0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/wps.20299","article-title":"Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder","volume":"15","author":"Mataix-Cols","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0195","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","article-title":"The Yale-Brown obsessive compulsive scale. II. Validity","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0200","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders","author":"First","year":"2007"},{"key":"10.1016\/j.cct.2017.12.017_bb0205","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archpsyc.1987.01800180050009","article-title":"The longitudinal interval follow-up evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies","volume":"44","author":"Keller","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004714-199310000-00005","article-title":"A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression","volume":"13","author":"Leon","year":"1993","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2017.12.017_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-3223(98)00126-7","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial","volume":"44","author":"Rosenbaum","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.20052","article-title":"Standard criteria for relapse are needed in obsessive-compulsive disorder","volume":"21","author":"Simpson","year":"2005","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.cct.2017.12.017_bb0225","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0149-7189(79)90094-6","article-title":"Assessment of client\/patient satisfaction: development of a general scale","volume":"2","author":"Larsen","year":"1979","journal-title":"Eval. Program Plann."},{"key":"10.1016\/j.cct.2017.12.017_bb0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0005-7916(00)00012-4","article-title":"Psychometric properties of the credibility\/expectancy questionnaire","volume":"31","author":"Devilly","year":"2000","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0235","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.cct.2017.12.017_bb0240","series-title":"Behavioural Psychotherapy","author":"Marks","year":"1986"},{"key":"10.1016\/j.cct.2017.12.017_bb0245","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1037\/a0019712","article-title":"Distress tolerance and psychopathological symptoms and disorders: a review of the empirical literature among adults","volume":"136","author":"Leyro","year":"2010","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.cct.2017.12.017_bb0250","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/da.20846","article-title":"Distress tolerance and obsessions: an integrative analysis","volume":"28","author":"Cougle","year":"2011","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.cct.2017.12.017_bb0255","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jbtep.2012.03.005","article-title":"Emotional distress and pain tolerance in obsessive-compulsive disorder","volume":"43","author":"Hezel","year":"2012","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0260","series-title":"Emot. Regul. Psychopathol","first-page":"283","article-title":"Emotions, Emotion Regulation, and Psychological Treatment: A Unified Perspective","author":"Fairholme","year":"2010"},{"key":"10.1016\/j.cct.2017.12.017_bb0265","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11031-005-7955-3","article-title":"The distress tolerance scale: development and validation of a self-report measure","volume":"29","author":"Simons","year":"2005","journal-title":"Motiv. Emot."},{"key":"10.1016\/j.cct.2017.12.017_bb0270","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.cct.2017.12.017_bb0275","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archpsyc.63.5.484","article-title":"Caution regarding the use of pilot studies to guide power calculations for study proposals","volume":"63","author":"Kraemer","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2017.12.017_bb0280","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cpr.2015.06.003","article-title":"Cognitive behavioral treatments of obsessive\u2013compulsive disorder. A systematic review and meta-analysis of studies published 1993\u20132014","volume":"40","author":"\u00d6st","year":"2015","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.cct.2017.12.017_bb0285","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cpr.2004.08.004","article-title":"A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder","volume":"24","author":"Eddy","year":"2004","journal-title":"Clin. Psychol. Rev."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714417307498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714417307498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:25:36Z","timestamp":1778819136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714417307498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":57,"alternative-id":["S1551714417307498"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2017.12.017","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2017.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}